Pulmonary Complications of Cirrhosis

被引:43
作者
Singh, C. [2 ]
Sager, J. S. [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Cottage Pulm Hypertens Ctr, Santa Barbara, CA 93105 USA
[2] Santa Barbara Cottage Hosp, Buellton, CA 93427 USA
关键词
Pulmonary hypertension; Hepatopulmonary syndrome; Portopulmonary hypertension; Hepatic hydrothorax; Liver transplantation; EXHALED NITRIC-OXIDE; HEPATOPULMONARY-SYNDROME; PORTOPULMONARY HYPERTENSION; LIVER-TRANSPLANTATION; PORTAL-HYPERTENSION; GAS-EXCHANGE; HEPATIC HYDROTHORAX; RAT MODEL; LONG-TERM; HYPOXEMIA;
D O I
10.1016/j.mcna.2009.03.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Advanced liver disease and portal hypertension produce various intrathoracic complications that involve the pleural space, the lung parenchyma, and the pulmonary circulation. Dyspnea and arterial hypoxemia are the most common symptoms and signs in patients with such complications. This article focuses on the diagnosis and management of hepatopulmonary syndrome, portopulmonary hypertension, and hepatic hydrothorax. All are pulmonary processes associated with end-stage liver disease that lead to significant morbidity and affect the quality of life of patients who are suffering from liver cirrhosis.
引用
收藏
页码:871 / +
页数:14
相关论文
共 65 条
  • [1] Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: A new approach
    Abrams, GA
    Nanda, NC
    Dubovsky, EV
    Krowka, MJ
    Fallon, MB
    [J]. GASTROENTEROLOGY, 1998, 114 (02) : 305 - 310
  • [2] Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome
    Almeida, John A.
    Riordan, Stephen M.
    Liu, Jia
    Galhenage, Sumedha
    Kim, Robert
    Bihari, David
    Wegner, Eva A.
    Cranney, Gregory B.
    Thomas, Paul S.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (04) : 341 - 346
  • [3] Barreales M., 2005, Rev. esp. enferm. dig., V97, P830, DOI 10.4321/s1130-01082005001100007
  • [4] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    Barst, RJ
    Rubin, LJ
    Long, WA
    McGoon, MD
    Rich, S
    Badesch, DB
    Groves, BM
    Tapson, VF
    Bourge, RC
    Brundage, BH
    Koerner, SK
    Langleben, D
    Keller, CA
    Murali, S
    Uretsky, BF
    Clayton, LM
    Jobsis, MM
    Blackburn, SD
    Shortino, D
    Crow, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) : 296 - 301
  • [5] Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation
    Battaglia, SE
    Pretto, JJ
    Irving, LB
    Jones, RM
    Angus, PW
    [J]. HEPATOLOGY, 1997, 25 (05) : 1228 - 1232
  • [6] Portopulmonary hypertension in decompensated cirrhosis with refractory ascites
    Benjaminov, FS
    Prentice, M
    Sniderman, KW
    Siu, S
    Liu, P
    Wong, F
    [J]. GUT, 2003, 52 (09) : 1355 - 1362
  • [7] EFFECTS OF PROSTAGLANDIN INHIBITION ON SYSTEMIC AND HEPATIC HEMODYNAMICS IN PATIENTS WITH CIRRHOSIS OF THE LIVER
    BRUIX, J
    BOSCH, J
    KRAVETZ, D
    MASTAI, R
    RODES, J
    [J]. GASTROENTEROLOGY, 1985, 88 (02) : 430 - 435
  • [8] Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients
    Castro, M
    Krowka, MJ
    Schroeder, DR
    Beck, KC
    Plevak, DJ
    Rettke, SR
    Cortese, DA
    Wiesner, RH
    [J]. MAYO CLINIC PROCEEDINGS, 1996, 71 (06) : 543 - 551
  • [9] Novel use of sildenafil in the treatment of portopulmonary hypertension
    Chua, R
    Keogh, A
    Miyashita, M
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (04) : 498 - 500
  • [10] ELEVATED EXHALED NITRIC-OXIDE IN PATIENTS WITH HEPATOPULMONARY SYNDROME
    CREMONA, G
    HIGENBOTTAM, TW
    MAYORAL, V
    ALEXANDER, G
    DEMONCHEAUX, E
    BORLAND, C
    ROE, P
    JONES, GJ
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (11) : 1883 - 1885